Related Experiment Video

Updated: May 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

The effect of vasopressin on the hemodynamics in CABG patients

Hu Yimin1, Liu Xiaoyu, Hu Yuping

  • 1Department of Anesthesiology, Jinling hospital, medical school of Nanjing University, Nanjing, 210002, PR China.

Journal of Cardiothoracic Surgery
|March 19, 2013
PubMed

Insights

Vasopressin demonstrated superior hemodynamic stability compared to norepinephrine in patients undergoing coronary artery bypass grafting (CABG) surgery. This suggests vasopressin may be a preferred agent for managing hypotension during CABG.

Area of Science:

  • Cardiovascular Anesthesiology
  • Pharmacology
  • Surgical Critical Care

Background:

  • Vasopressin is a common treatment for hypotension, but its effects in coronary artery bypass grafting (CABG) patients remain unclear.
  • This study aimed to clarify vasopressin's hemodynamic impact in CABG patients.

Purpose of the Study:

  • To investigate the effects of vasopressin versus norepinephrine on hemodynamic parameters in patients undergoing CABG surgery.
  • To compare the efficacy of vasopressin and norepinephrine in maintaining hemodynamic stability during CABG.

Main Methods:

  • Twenty coronary artery disease patients were randomized into norepinephrine or vasopressin groups.
  • Hemodynamic parameters including mean artery pressure (MAP), heart rate (HR), central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), and pulmonary artery pressure (PAP) were continuously monitored.
  • Pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) were assessed during critical surgical phases.

Main Results:

  • Both vasopressin and norepinephrine maintained stable mean artery pressure (MAP) and heart rate (HR).
  • Vasopressin showed a significant advantage in preventing increases in pulmonary vascular resistance (PVR) during artery grafting compared to norepinephrine.
  • Metoprolol usage was significantly lower in the vasopressin group, indicating potentially fewer cardiac complications.

Conclusions:

  • Vasopressin offers superior hemodynamic stability compared to norepinephrine in CABG patients.
  • Vasopressin may be a more effective agent for managing hypotension during CABG surgery.
  • Further research is warranted to explore vasopressin's long-term benefits in CABG patients.
Abstract

More Related Videos

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.